Company / Depreciation & Amortization
Regenerative Medical Technology Group Inc. Depreciation & Amortization History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$281.1K
FY2025
5-year range
$40.9K / $310.1K
FY2021-FY2025
Trend
+27.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $310,102 to $281,067 over the past 2 years.
Based on SEC 10-K filings.
$281,067 in FY2025 with a 5-year CAGR of +223.0%.
Improved from $310,102 to $281,067 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +22.5%
- 5-Year CAGR
- +223.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +223.0%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 27.4% year-over-year.
- Peak depreciation & amortization was recorded in FY2023.
- Lowest depreciation & amortization in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $281.1K | +27.4% |
| FY2024 | $220.6K | -28.9% |
| FY2023 | $310.1K | +103.0% |
| FY2022 | $152.7K | +273.8% |
| FY2021 | $40.9K | +5007.3% |
| FY2020 | $800 | +0.0% |
| FY2019 | $800 | +300.0% |
| FY2018 | $200 | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026